Nanoviricides NNVC
NYSE NNVC
$1.39 -0.12 (-7.95%)
At close: Oct 22, 2026 · 4:00 PM EDT

Nanoviricides (NNVC) Selling, General & Administrative (2010 - 2026)

Updated

Nanoviricides (NNVC) reported Selling, General & Administrative of $936,316 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 0.2% from $938,195 a year earlier but up 25.8% from the prior quarter.

Analysis

Nanoviricides (NNVC) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Nanoviricides posted Selling, General & Administrative of $3.6 million, down 11.0% from FY2025.

  • Selling, General & Administrative has a five-year compound annual growth rate of 6.5% (FY2021 to FY2026).
  • By fiscal year, Selling, General & Administrative came in at $4.04 million in FY2025 (+31.3%), $3.08 million in FY2024 (+20.7%), $2.55 million in FY2023 (+9.5%) and $2.33 million in FY2022 (-11.4%).
  • Five-year quarterly Selling, General & Administrative spans a low of $509,701 in fiscal Q1 2023 and a high of $1.23 million in fiscal Q1 2025.
  • Year over year, Selling, General & Administrative gained in four of the last eight quarters, with growth averaging 18.6%.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q1 2025 (growth of 118.6%); the low point was fiscal Q1 2026 (a decline of 34.9%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $744,276 (Q3 2026), $1.11 million (Q2 2026) and $803,619 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Nanoviricides 31.98 Mn 19.64 Mn - 936,316.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 936,316.00
Mar 31, 2026 744,276.00
Dec 31, 2025 1.11 Mn
Sep 30, 2025 803,619.00
Jun 30, 2025 938,195.00
Mar 31, 2025 966,905.00
Dec 31, 2024 902,700.00
Sep 30, 2024 1.23 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 693,742.00
Dec 31, 2023 610,877.00
Sep 30, 2023 564,926.00
Jun 30, 2023 763,422.00
Mar 31, 2023 614,647.00
Dec 31, 2022 663,284.00
Sep 30, 2022 509,701.00
Jun 30, 2022 621,223.00
Mar 31, 2022 532,801.00
Dec 31, 2021 659,268.00
Sep 30, 2021 515,445.00
API Access

Nanoviricides Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NNVC&period=max&api_key=YOUR_API_KEY